Clinical Trials

Showing trials with last updates posted in 2026.

NCT06789913 | RECRUITING | PHASE2
277 participants

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-25
Start Date:
2025-06-13
Completion:
2031-07-31
Conditions
  • PIK3CA-Related Overgrowth Spectrum (PROS)
  • Lymphatic Malformations
  • Vascular Malformations
  • PIK3CA Mutation
  • CLOVES Syndrome
  • Klippel Trenaunay Syndrome
  • Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)
  • Vascular Anomalies
Interventions
  • DRUG
No Results Yet
NCT06676956 | RECRUITING | NA
320 participants

The SEQUENCE Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-25
Start Date:
2024-11-10
Completion:
2027-08-31
Conditions
  • Pulmonary Nodules
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page